Metabolic & Weight Research
Tirzepatide 10mg
Tirzepatide 10mg
Two incretin pathways. One high-interest metabolic target.
Dual-pathway metabolic research built around GIP and GLP-1 signalling, with established relevance to appetite, glucose and energy-balance pathways.
- Documentation
- Check batch record
- Availability
- In stock
For qualified laboratory research only · Not for human or veterinary use
Why researchers choose it
Tirzepatide activates both GIP and GLP-1 receptors, making it a valuable reference molecule for studying how incretin signalling shapes appetite, glucose handling and energy balance.
Research focus
- Dual GIP and GLP-1 receptor signalling
- Appetite and satiety pathway research
- Glucose and energy-balance models
Evidence snapshot
Tirzepatide is approved in specific regulated medicines, but those product-level outcomes and authorizations do not transfer to this Apex vial. Identity, formulation, quality and approval remain product-specific.
Best suited to
For controlled metabolic-signalling research with defined assays and documented endpoints.
Research focus describes published study domains, not a guaranteed outcome. No human or veterinary dosing, reconstitution or administration instructions are supplied.
Related research compounds
Metabolic & Weight10mg
A supplier-named formulation reserved for composition, identity and formulation research; exact ingredients must be established from the matching lot record.
Metabolic & Weight15mg
Triple-pathway research across GIP, GLP-1 and glucagon signalling—the combination driving next-generation interest in appetite, glucose and energy expenditure.